Long-term Prognosis in Stroke Patients

March 22, 2021 updated by: Ji Hoe Heo, Severance Hospital
A single-center cohort of patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university and their long-term outcomes.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This is a single-center cohort of consecutive patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university in Republic of Korea.

Stroke recurrence, Cardiovascular event, all cause mortality and cardiovascular mortality were collected through long-term follow up.

Study Type

Observational

Enrollment (Anticipated)

9000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ji Hoe Heo, MD, PhD
  • Phone Number: 82-2-2228-1605
  • Email: jhheo@yuhs.ac

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients with acute ischemic stroke/transient ischemic attack

Description

Inclusion Criteria:

  • All patients with acute ischemic stroke or transient ischemic attack

Exclusion Criteria:

  • A patient who did not agree with enrollment of this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Long-term follow up, observational
This cohort does not involve interventions, just follow up of prognosis of ischemic stroke/transient ischemic attack patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Event of Stroke or transient ischemic attack
Time Frame: through study completion, up to 10 years
The time of a stroke or transient ischemic attack occurs (through study completion)
through study completion, up to 10 years
Event of cardiovascular disease (include stroke/transient ischemic attack)
Time Frame: through study completion, up to 10 years
The time of a cardiovascular disease (stroke/transient ischemic attack) occurs (through study completion)
through study completion, up to 10 years
All cause mortality
Time Frame: through study completion, up to 10 years
The time of death from any cause (through study completion)
through study completion, up to 10 years
Cardiovascular cause mortality (include stroke/transient ischemic attack mortality)
Time Frame: through study completion, up to 10 years
The time of death from cardiovascular cause (through study completion)
through study completion, up to 10 years
The modified Rankin Scale (mRS)
Time Frame: 3 months
Measure functional outcome as the form of mRS at 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Severance Hospital

Investigators

  • Study Chair: Ji Hoe Heo, MD, PhD, Yonsei University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

December 28, 2016

First Submitted That Met QC Criteria

April 17, 2018

First Posted (Actual)

April 27, 2018

Study Record Updates

Last Update Posted (Actual)

March 24, 2021

Last Update Submitted That Met QC Criteria

March 22, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-2011-0731

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe